Back to UBS Group AG UBS Group AG

CLDICLDI
4 quarters

Position history for UBS Group AGUBS Group AG's holdings in CALIDI BIOTHERAPEUTICS INC

UBS Group AG holds 7,882 shares of CLDI (CALIDI BIOTHERAPEUTICS INC), worth $1,340 as of 2026-Q2. This is a new position.

Current Value

$1,340

Current Shares

7,882

Total Value Change

-$2,557

Total Shares Change

+5,318

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
7,882
-
$1,3400.0%$2.72
17
2026-Q1
Exited
0
-100.0%
$00.0%$3.82
0
2025-Q4
Increased
7,514
+193.1%
$8,7920.0%$18.72
18
2025-Q3
New
2,564
-
$3,8970.0%$24.32
22

Other major holders of CLDI: HighTower Advisors, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used